Endometriosis Trial, Recruiting NCT07686783 Sponsor: Benha University Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT07686783
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 18 and 45 years of age
  • People who have an ovarian cyst between 6 and 15 centimetres in size, confirmed by an internal ultrasound or MRI scan
  • People whose cyst has been present for more than 3 months without causing symptoms, OR people who have a cyst causing symptoms regardless of how long it has been present
  • People whose most recent blood test (taken within one month before any procedure) shows a hormone level called AMH at 2 ng/mL or above
  • People who are willing to take part and able to sign a written consent form

Who may not be able to join:

  • People where there is any concern, based on examination or ultrasound, that the cyst may be cancerous
  • People whose cyst is related to a pregnancy
  • People who have had previous surgery on their ovaries
  • People who have had radiation therapy or chemotherapy to the pelvic area in the past
  • People with a known hormonal condition affecting how the ovaries work, such as polycystic ovary syndrome (PCOS), early ovarian failure, thyroid problems, or high prolactin levels
  • People who have used hormonal contraceptives or hormonal therapy within the 3 months before joining the trial
  • People with a serious health condition that makes surgery or general anaesthetic unsafe
  • People who are unwilling to participate or are unable to provide consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: AHMED ALNEZAMY, MD, Lecturer of Obstetrics and Gynecology, Faculty of Medicine, Benha University

Phone: 01224849065

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Benha University
Registry
ClinicalTrials.gov
Start date
30 June 2026
Est. completion
1 June 2027

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Absolute Change in Serum Anti-Müllerian Hormone (AMH) Level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov